Hims & Hers (HIMS) is down -12.0%, or -$3.42 to $25.13.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Unusually active option classes on open December 19th
- Hims & Hers initiated with an Overweight at Morgan Stanley
- Ro, Lilly partnership creates volatility for Hims & Hers shares, says Leerink
- BofA views news of Lilly selling Zepbound through Ro as ‘mixed’ for Hims & Hers
- ADA advises doctors, patients not to use compounded GLP-1s